Hepatitis

All articles by Hepatitis

Five things for pharma marketers to know: Monday, November 13, 2017
Five things for pharma marketers to know: Monday, November 13, 2017
Virginia Lau
November 13, 2017
3:15 pm

Dynavax receives FDA approval for hepatitis-B vaccine; Novartis strikes R&D deal with gene-editing startup; White House nominates new HHS head

Infographic | The leaders of the global hepatitis-C market
Infographic | The leaders of the global hepatitis-C market
Virginia Lau
August 31, 2017
11:00 am

Despite approvals of competing products from AbbVie, Merck, and Bristol-Myers Squibb, Gilead remains the market leader.

Three kinds of drugs, like those that treat RA and diabetes, drive increase in spending
Three kinds of drugs, like those that treat RA and diabetes, drive increase in spending
Virginia Lau
February 8, 2017
2:30 pm

Spending for inflammatory drugs like AbbVie’s Humira and Amgen’s Enbrel rose, while hepatitis C drugs showed decline.

Drugmakers set their sights on the next potential blockbuster disease: NASH
Drugmakers set their sights on the next potential blockbuster disease: NASH
Kevin McCaffrey
September 29, 2016
2:14 pm

A race has emerged in a new disease space estimated to be worth billions of dollars.

Five things for pharma marketers to know: Tuesday, May 5
Five things for pharma marketers to know: Tuesday, May 5
Deborah Weinstein
May 5, 2015
3:23 pm

Worldwide spending on cancer medications hit $100 billion last year; Bayer adds an anticoagulant to its pipeline for $100 million; GlaxoSmithKline has a new chairman

Five things for pharma marketers to know: Friday, April 24
Five things for pharma marketers to know: Friday, April 24
Deborah Weinstein
April 24, 2015
3:30 pm

An AbbVie hep.-C drug nabbed priority review; Merck’s hep.-C drug matches efficacy of Harvoni; Mylan increased its bid to buy Perrigo

Mylan’s generic Sovaldi launches in India
Mylan’s generic Sovaldi launches in India
April 23, 2015
5:30 pm

The hepatitis-C drug is being sold under the name MyHep.

Medicare shelled out more than $4.7 billion on hep C last year
Medicare shelled out more than $4.7 billion on hep C last year
March 30, 2015
7:00 pm

Key contributors to the total: Sovaldi, Harvoni and Olysio

Report: US drug spending jumped 13% in 2014
Report: US drug spending jumped 13% in 2014
Deborah Weinstein
March 10, 2015
8:30 pm

PBM Express Scripts said last year’s trends reflect a major shift in how the pharmaceutical industry does business and that generics are not the bargain they once were.

Five things for pharma marketers to know: Tuesday, March 10
Five things for pharma marketers to know: Tuesday, March 10
Deborah Weinstein
March 10, 2015
4:50 pm

HCV drugs and other specialty medications drove a 13% increase in last year’s prescription spending, the CBO overestimated just how much healthcare reform would cost, and an FDA panel voted 17-0 in favor of Kythera’s drug that can reduce double chins.

  • From Our Partners